156 related articles for article (PubMed ID: 12099517)
1. Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation.
International Neoral Renal Transplantation Study Group.
Am J Transplant; 2002 Feb; 2(2):148-56. PubMed ID: 12099517
[TBL] [Abstract][Full Text] [Related]
2. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
Canadian Neoral Renal Transplantation Study Group
Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
[TBL] [Abstract][Full Text] [Related]
3. Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis.
Internation Neoral Renal Transplantation Study Group
Am J Transplant; 2002 Feb; 2(2):157-66. PubMed ID: 12099518
[TBL] [Abstract][Full Text] [Related]
4. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation.
Mahalati K; Belitsky P; Sketris I; West K; Panek R
Transplantation; 1999 Jul; 68(1):55-62. PubMed ID: 10428267
[TBL] [Abstract][Full Text] [Related]
5. A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group.
Keown P; Landsberg D; Halloran P; Shoker A; Rush D; Jeffery J; Russell D; Stiller C; Muirhead N; Cole E; Paul L; Zaltzman J; Loertscher R; Daloze P; Dandavino R; Boucher A; Handa P; Lawen J; Belitsky P; Parfrey P
Transplantation; 1996 Dec; 62(12):1744-52. PubMed ID: 8990355
[TBL] [Abstract][Full Text] [Related]
6. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection.
Weber LT; Armstrong VW; Shipkova M; Feneberg R; Wiesel M; Mehls O; Zimmerhackl LB; Oellerich M; Tönshoff B;
Ther Drug Monit; 2004 Aug; 26(4):415-24. PubMed ID: 15257072
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profiling of cyclosporine microemulsion during the first 3 weeks after simultaneous pancreas-kidney transplantation.
Wacke R; Kundt G; Gock M; Klar E; Drewelow B; Schareck W
Transplant Proc; 2006 Apr; 38(3):751-2. PubMed ID: 16647462
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal evaluation of the pharmacokinetics of cyclosporin microemulsion (Neoral) in pediatric renal transplant recipients and assessment of C2 level as a marker for absorption.
Trompeter R; Fitzpatrick M; Hutchinson C; Johnston A
Pediatr Transplant; 2003 Aug; 7(4):282-8. PubMed ID: 12890006
[TBL] [Abstract][Full Text] [Related]
11. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.
Hangler HB; Ruttmann E; Geltner C; Bucher B; Nagiller J; Laufer G; Mueller LC
Clin Transplant; 2008; 22(1):35-40. PubMed ID: 18217903
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cyclosporine absorption profiles over a 12-month period in stable pediatric renal transplant recipients.
Wigger M; Drückler E; Muscheites J; Stolpe HJ; Kundt G; Wacke R
Transplant Proc; 2003 Jun; 35(4):1300-3. PubMed ID: 12826143
[TBL] [Abstract][Full Text] [Related]
13. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
Keown P; Niese D
Kidney Int; 1998 Sep; 54(3):938-44. PubMed ID: 9734620
[TBL] [Abstract][Full Text] [Related]
15. Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).
Jaksch P; Kocher A; Neuhauser P; Sarahrudi K; Seweryn J; Wisser W; Klepetko W
J Heart Lung Transplant; 2005 Aug; 24(8):1076-80. PubMed ID: 16102443
[TBL] [Abstract][Full Text] [Related]
16. Dose adjustment strategy for oral microemulsion formulation of cyclosporine: population pharmacokinetics-based analysis in kidney transplant patients.
Tokui K; Kimata T; Uchida K; Yuasa H; Hayashi Y; Itatsu T; Nabeshima T
Ther Drug Monit; 2004 Jun; 26(3):287-94. PubMed ID: 15167630
[TBL] [Abstract][Full Text] [Related]
17. A limited sampling strategy for the estimation of 12-hour Neoral systemic drug exposure in heart transplant recipients.
Balram C; Sivathasan C; Cheung YB; Tan SB; Tan YS
J Heart Lung Transplant; 2002 Sep; 21(9):1016-21. PubMed ID: 12231373
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
[TBL] [Abstract][Full Text] [Related]
19. A limited sampling strategy for the estimation of eight-hour neoral areas under the curve in renal transplantation.
Meier-Kriesche HU; Kaplan B; Brannan P; Kahan BD; Portman RJ
Ther Drug Monit; 1998 Aug; 20(4):401-7. PubMed ID: 9712465
[TBL] [Abstract][Full Text] [Related]
20. Clinical success of Neoral absorption profile.
Uchida K; Tominaga Y; Haba T; Katayama A; Matsuoka S; Goto N; Ueki T; Kimata T; Takeda A; Morozumi K; Takagi H; Nakao A
Transplant Proc; 2004 Mar; 36(2 Suppl):461S-464S. PubMed ID: 15041388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]